Fertilization is well correlated with sperm concentration, rate of forward motility, and percentage of live, uncapacitated ejaculated spermatozoa, which is regulated in part by cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Phosphodiesterases (PDEs) hydrolyze cyclic nucleotides to their corresponding monophosphates, thereby counterbalancing the activities of cAMP and cGMP, and PDE11 is highly expressed in the testis, prostate, and developing spermatozoa. However, a physiological role of PDE11 is not known. We generated PDE11 knockout (PDE11 À/À ) mice to investigate the role of PDE11 in spermatozoa physiology. Ejaculated sperm from PDE11 À/À mice displayed reduced sperm concentration, rate of forward progression, and percentage of live spermatozoa. Pre-ejaculated sperm from PDE11 À/À mice displayed increased premature/spontaneous capacitance. These data are consistent with human data and suggest a role for PDE11 in spermatogenesis and fertilization potential. This is the first phenotype described for the PDE11 À/À mouse and the first report of a physiological role for PDE11.
Introduction
Mammalian sperm cannot fertilize eggs at the time of release from the male reproductive tract after ejaculation, but gain this capacity after a finite residence within the female reproductive tract. 1 The series of physiological changes that renders sperm capable of fertilization is termed capacitance and includes the acquisition of forward motility and the potential to undergo the acrosome reaction. Capacitance, which ultimately leads to the acrosome reaction and cell death, was first described more than 50 y ago and is essential for egg fertilization. [2] [3] [4] [5] The brief lifespan of capacitated spermatozoa requires a highly coordinated sequence of events for proper sperm performance and fertilization to occur, which may be regulated by the second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Evidence for a role of cAMP in spermatozoa physiology includes the G-protein-regulated, membrane-bound (mAC) and bicarbonate-dependent, soluble (sAC) adenylyl cyclases, and the cAMP-responsive element modulator (CREM), which regulates gene expression necessary for gamete development. 6 The expressions of mAC and sAC appear first in the pachytene spermatocytes, increase during spermatogenesis, and are involved in the synthesis of cAMP. [7] [8] [9] Changes in cAMP regulate the activity of CREM and have been linked to important physiological processes such as epididymal sperm maturation, motility, capacitance and the acrosome reaction. 10 Phosphodiesterases (PDEs) catalyze the hydrolysis of cyclic nucleotides at physiologically relevant concentrations, thus counterbalancing the activity of adenylyl and guanyl cyclases. There are 11 known families of PDEs (PDE1-PDE11), and variants within families, that play critical roles in cAMP-and cGMP-regulated signal transduction pathways. [11] [12] [13] Knockout studies of PDE3 and PDE4 suggest a role for PDEs in oocyte development and female fertility. 14, 15 PDE11 is the most recently cloned and characterized PDE 16, 17 and is expressed in skeletal muscle, heart (cardiac myocytes), pituitary, intestines, liver, and kidney. 16 PDE11 is highly expressed in the male reproductive tract, including prostate, testes and developing spermatozoa (spermatogonia, spermatocytes, spermatids and Leydig cells). 16 The catalytic domain of PDE11 is highly conserved with that of other PDE family members, and PDE11 is most closely related to PDE5. 16 However, PDE5 is highly specific for cGMP (K m o0.01 mM), whereas PDE11 is a dual substrate enzyme with a low K m for both cAMP and cGMP (1.04 and 0.52 mM, respectively). 16 The tissue-specific distribution and substrate specificity suggest a different function of PDE11. However, a physiological role for PDE11 is not yet known.
We generated mice lacking PDE11 (PDE11
) to test the hypothesis that PDE11 plays a role in sperm physiology. We describe the first phenotype of the PDE11 À/À mouse, and present the first physiological function for PDE11.
Experimental procedures

Construction of the targeting vector
The murine sequence of PDE11 was not available at the time of targeting vector development, but has been subsequently determined. The human PDE11A1 sequence (GenBank accession number AJ251509) 16 was used due to its high homology with the murine sequence: 90% identical at the nucleic acid level and 92% identical at the protein level. We replaced 16 base pairs of human PDE11A1 (AJ251509) with a Lac-Z/Neo r selection cassette, which disrupted a portion of the catalytic domain of human PDE11A1 encoded by exon 12 ( Figure 1 ). The resultant targeting vector had 2.5 Kb of homologous sequence 5 0 and 4.0 Kb of homologous sequence 3 0 to the Lac-Z/Neo r insertion, and ensured ablation of all known PDE11A splice variants.
Electroporation
Mouse 129/SvJ embryonic stem (ES) cells were transformed by established techniques. 18 Briefly, ES cells were plated in 100 mm gelatinized tissue culture dishes at 371C in a humid atmosphere containing 5% CO 2 . After 24 h, cells were provided fresh ES cell medium for 4 h, then resuspended in ES cell medium to a final concentration of 12.5 Â 10 6 cells/ml. The targeting construct was linearized and 2 mg was added to the ES cells in an electroporation cuvette. Cells were electroporated using a BTX ECM electroporator (BTX Molecular Delivery Systems, Genetronics Biomedical Corporation, San Diego, CA, USA), and cells were replated in ES cell medium supplemented with 400 mg/ml G418, an antibiotic used to select cells with incorporation of targeting vector containing the neomycin (Neo) resistance selection gene (Figure 1 ). After 13 days, clones were divided for Southern blot analysis and for frozen storage.
Southern blot analysis
Genomic DNA was isolated from ES cells using standard procedures. DNA was digested overnight with NcoI, which was cleaved outside of the 5 0 arm of the targeting vector, separated by electrophoresis through 0.8% agarose gels, and was transferred to nitrocellulose membranes. Membranes were crosslinked by UV irradiation, and prehybridized for 2-5 h in a prehybridization solution containing herring sperm DNA. Bands were visualized by overnight hybridization at 421C using a 32 P-radiolabeled fragment of PDE11A that hybridized outside of, and adjacent to, the construction arm. Regulation of spermatozoa physiology C Wayman et al
Generation of PDE11
À/À mice G418-resistant ES cell clones with the correct homologous recombination were injected into blastocysts from C57BL/6 mice. 19 Briefly, blastocysts were isolated from superovulated female mice, and 6-10 targeted 129/SvJ ES cells were injected into the blastocoel of each blastocyst. Roughly 160 blastocysts were injected and reimplanted into the uteri of pseudopregnant C57BL/6 female mice. In all, 19 male chimeras were derived and mated with C57BL/ 6 females. Ablation of PDE11 was confirmed by RT-PCR analysis of DNA isolated from the tail tip of 2-3-week-old pups. All animal housing and experimentation complied with national legislation and all procedures and practices were ethically reviewed and approved by institutional animal care and use committees.
RT-PCR analysis
Total RNA was isolated from the testis of PDE11
and PDE11
þ / þ mice and cDNA was generated from 5 mg of each RNA sample using a SuperScriptt FirstStrand Synthesis kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The primer pairs were designed to generate an expected band size of 720 bp of PDE11, which is common to all PDE11 splice variants. The PCR products were subsequently separated by gel electrophoresis in 1% agarose gels containing 0.5 mg/ml ethidium bromide and visualized by UV detection.
Cytochemistry
To visualize functional expression of b-galactosidase from the Lac-Z/Neo r targeting vector, frozen 8 mM sections of aorta, prostate, and testis from PDE11 À/À mice were cut using a cryostat, placed on glass microscope slides, with a fixation buffer for 15 min at room temperature, and rinsed with PBS. Subsequently, tissues were stained with 50 mg/ml X-gal overnight at 371C. Tissues were rinsed in PBS, fixed again and counterstained with Nuclear Fast Red (Promega, Madison, WI, USA) for 1 min. Slides were rinsed and sealed with a coverslip and digital images were obtained.
Immunohistochemistry
Protein expression of PDE11 has been demonstrated in human tissues using a rabbit polyclonal antibody, raised against amino-acid residues 410-424 (SAIFDRNRKDELPRL) of human PDE11A1, 16 which is common to all known PDE11 splice variants and murine PDE11 (unpublished data). To confirm ablation of PDE11 in the testis and developing spermatozoa, tissue sections of testes from PDE11 À/À and PDE11 þ / þ mice were processed into 5 mM thick sections and mounted on 3-aminopropyltriethoxysilane (APES)-coated slides. PDE11 antiserum (4.2 mg/ml) was affinity-purified against the immobilized peptide (Cambridge Research Biochemicals, Billingham, UK) and applied at dilutions of 1:400, 1:1000, and 1:2000. Preimmune serum was used as a negative control. Slides were subsequently washed in TBS/Tween-20 and stained with H&E counterstain. The primary antibody was visualized by light microscopy using the DAKO EnVision þ system (DAKO Corporation, Carpinteria, CA, USA), which stains positive cells brown. Slides were mounted in DPX, sealed with a coverslip, and digital images were obtained.
Sperm collection
All mice were euthanized by exposure to CO 2 , and all subsequent physiologic assays were blinded. The vas deferens and cauda epididymides were isolated from PDE11
À/À and PDE11 þ / þ mice by microdissection. Tissues were immediately placed in an organ culture dish filled with 1 ml of human tubal fluid (Zavos Diagnostic Laboratories, Lexington, KY, USA), which mimics the physiological environment of the fallopian tubes, plus 21 mM HEPES supplemented with 0.4% bovine serum albumin prewarmed to 371C and covered with light mineral oil. Working under oil, the contents of each vas deferens were expelled by gentle squeezing and placed in a 371C incubator in an atmosphere of 5% CO 2 and 95% humidity for 10-20 min to allow the sperm to 'swim out'.
Concentration
Sperm concentration was determined using a hemacytometer. Specifically, each sperm sample was diluted 20-fold with water, and 10 ml of this suspension was used to fill each side of the chamber via capillary action. Cells from five (of 25) 0.2 mm randomly selected squares were counted and the sperm concentration was determined by the average number of cells in five 0.2 mm squares Â 50 000 Â 20 (or the dilution factor).
Motility and rate of forward movement
Motility and forward movement were determined at a magnification of Â 200, utilizing a Nikon TE-2000 
Sperm capacitance
The chlortetracycline (CTC) fluorescence assay was used to assess the capacitance of pre-ejaculated sperm (ie, non-ejaculated, hence removed from testes/epididymides) as described previously. 20, 21 Spermatozoa were observed using an Olympus BX40 microscope equipped with a wide blue-violet excitation cube (U-MWBV), BX-FLA excitation filters (set at 400-440 nM) and a DM455 dichroic mirror. In each sample, 100 cells were classified as having one of three staining patterns: Full, fluorescence over the whole head, characteristic of uncapacitated, acrosome-intact spermatozoa; Band, fluorescence-free band in the postacrosomal region, indicating capacitated, acrosome-intact cells; and Acrosome Reacted (AR), dull or absent fluorescence, characteristic of capacitated, acrosome-reacted spermatozoa. The number of Full, Band, and AR spermatozoa was counted for a minimum of 200 spermatozoa, from at least 10 different fields, and the percentage of capacitated sperm was calculated.
Statistics
Differences between PDE11
þ / þ and PDE11 À/À mice were determined by Student's t-test at the 5% level of significance.
Results
Generation of PDE11
À/À mice
The genomic structure of PDE11 is shown in Figure 1a . The Lac-Z-Neo selection cassette replaced 16 nucleotide base pairs in exon 12, which encodes a portion of the catalytic domain of PDE11 (Figure 1b) . The presence or absence of the targeting vector in G418-resistant ES cells was visualized by Southern blot analysis. The parental ES cell lines ( þ / þ ) were used as negative controls and showed a single band representing the wild-type PDE11 gene. The targeted ES cells ( þ /À) showed a second, smaller band (roughly 9.4 kb) representing the knockout allele from the expected recombination event (Figure 1c) . ES cell clones with the correct homologous recombination of the vector were used for blastocyst injections. Mice heterozygous (PDE11 þ /À ) for the mutation were interbred to produce homozygous PDE11 À/À mice. Expression of PDE11 was demonstrated by RT-PCR (Figure 1d ). An expected band of 720 bp was observed in PDE11 þ / þ mice and was absent in PDE11 À/À mice derived from ES cells with the correct homologous recombination.
Adult PDE11
À/À mice have no gross abnormalities Homozygous adult PDE11 À/À mice were viable, produced with the expected 25% Mendelian percentage and did not exhibit any gross anatomical abnormalities. The fertility rate of PDE11 À/À mice was similar to that of PDE11 þ /À and PDE11
mice. Histological sections of tissue from PDE11
À/À mice reveal no changes in morphology from PDE11 þ / þ mice and confirm expression of bgalactosidase from the targeting vector (Figure 2a) . Positive staining for b-galactosidase appears blue, which is absent from the aorta, but present in the prostate and testes. Successful interruption and ablation of PDE11 expression was confirmed by RT-PCR (Figure 1d ) and immunohistochemistry. PDE11 expression was observed in the testes and developing spermatozoa of PDE11 þ / þ mice, but was absent in the testis of PDE11 À/À mice, including spermatagonia, spermatocytes, and spermatids (Figure 2b ). Positive staining of PDE11 appears brown and is absent in tissue from PDE11 À/À mice.
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Motility
Ejaculated sperm from PDE11 À/À mice displayed an overall motility similar to age-matched PDE11 þ / þ mice (Figure 3a) . However, the forward progression of ejaculated sperm from PDE11 À/À mice was reduced by 24% compared to that of PDE11 þ / þ sperm (2.270.2 vs 2.970.1, Po0.05) (Figure 3b ).
Concentration
Moreover, the concentration ( Â 10 6 /ml) of ejaculated sperm from PDE11 À/À mice was significantly lower than that of ejaculated sperm from PDE11 þ / þ mice (23.871.1 vs 29.371.7, Po0.05) (Figure 3c ).
Live spermatozoa
The percentage of live sperm from PDE11 À/À mice was also significantly lower (4572.4 vs 5671.4%, Po0.001) (Figure 3d ).
Capacitance
Tightly controlled regulation of sperm capacitance, which normally occurs after ejaculation from the male reproductive tract, is essential to maintain the proper fertilization potential of spermatozoa. The CTC assay identified capacitated spermatozoa by a loss of fluorescence in the post-acrosomal region (Band) or over the entire spermatozoa head þ / þ mice (n ¼ 4 (age-matched pups from different females), Z2 replicates from each mouse), and capacitance was determined using the CTC fluorescence assay. Data are mean7s.e. P-values were determined using Student's paired t-test. *Po0.05, 
Discussion
This is the first report describing a phenotype for the PDE11 À/À mouse and a role for PDE11 in sperm physiology. Targeted disruption of PDE11 gene and protein expression resulted in spermatozoa with reduced forward motility and increased premature or spontaneous capacitance (sperm activation). The increased percentage of capacitated sperm from PDE11 À/À mice suggests that premature/spontaneous activation and the acrosome reaction (and ultimately cell death) occurred within the testis/ epididymides, and resulted in the reduced number of live ejaculated sperm from PDE11 À/À mice. These data suggest that PDE11 plays a role in keeping spermatozoa in an un-capacitated state (prior to switching on at ejaculation) and that premature capacitance/activation of sperm could lead to early apoptosis and reduced fertilization potential.
Fertilization potential of mammalian sperm is well correlated with forward motility, sperm concentration, the percentage of live and uncapacitated spermatozoa at ejaculation. 10 Our data, and others, suggest that PDE11 may be clinically relevant for male fertility. A randomized, double-blind, crossover trial studying semen characteristics in men younger than 40 y identified significant differences between the effects of sildenafil (Viagra s , a PDE5 inhibitor) 22 and tadalafil (Cialis s , a combined PDE5 and PDE11 inhibitor). 22 The trial showed that sildenafil increased sperm concentration and straight-line velocity, a component of forward motility, which was significantly reduced by tadalafil. 23 It is possible that these effects are attributable to tadalafil's inhibition of PDE11 since inhibition of PDE5 appears to be associated with increased spermatozoa function. 24, 25 Others suggest that PDE11 inhibition is generally safe in men older than 45 y. 26 However, in that study, men with extremely high sperm concentration were used (70-80 million/ml) and straight-line velocity was not assessed. For younger couples, who may have fertility problems, a decrease in sperm motility may significantly impact the fertilization potential. Indeed, the full dose prescribing information contained within the Cialis label states, 'Tadalafil inhibits human recombinant PDE11A1 activity at concentrations within the therapeutic range'. Weeks et al 27 challenge this assertion and state that 'ythese drugs are very unlikely to cross-react with PDE11A4 in patients taking the prescribed dosagey' However, using the IC 50 and C max for tadalafil, the free plasma concentration of a single 20 mg dose of tadalafil may result in levels that are 410-fold higher than the IC 50 required to inhibit PDE11. Sildenafil and vardenafil (Levitra s ) are both nearly 1000-fold more selective for PDE5 than PDE11. Nevertheless, in the absence of clinical data on the impact of a selective PDE11 inhibitor on sperm physiology, we can only make inferences based on the similarities and differences in the pharmacological properties of agents tested to date.
Our data support a role for PDE11 in spermatozoa physiology and add to the recent advances in our understanding of the molecular regulation of spermatozoa capacitance (Figure 4) . The recently identified human testicular olfactory receptor, hOR17-4, 28 and the cAMP-regulated Ca 2 þ ion channel expressed specifically in the sperm, termed CatSper, [29] [30] [31] are important components of the fertilization process and may play significant roles in cAMP-mediated regulation of capacitance. In spermatozoa, ligand-odorant activation of hOR17-4, with compounds such as bourgeonal, lilial and floralozone, stimulates mAC 32 and sAC À/À mice have severely impaired motility and complete lack of forward progression, and are unable to fertilize intact eggs or zona pellucida null eggs in vitro. Moreover, the mAC-specific inhibitor, SQ22536, prevented spermatozoan Ca 2 þ signaling, chemotaxis and hyperactivation. 34 Consistent with these studies, PDE11
À/À mice were grossly normal, but the sperm from PDE11 À/À mice had reduced forward progression, suggesting that sperm from PDE11 À/À mice, too, may fail to fertilize oocytes. Additionally, PDE11 may participate in the regulation of spermatogenesis. Gene expression necessary for proper sperm development is regulated by the CREM, 6 which downregulates cAMP-mediated gene expression. Male mice lacking CREM have a significant increase in apoptotic germ cells, early spermatids that are arrested in the first step of spermatogenesis, and completely lack mature spermatozoa. 6 Although the ejaculated spermatozoa from PDE11 À/À mice appear fully developed, the sperm concentration and percentage of live ejaculated spermatozoa were reduced compared with that of PDE11 þ / þ mice. Enhancement of cAMP levels in spermatozoa from PDE11 À/À mice may override the Regulation of spermatozoa physiology C Wayman et al downregulation of cAMP-mediated gene transcription by CREM, leading to a suppression of spermatogenesis. Support for this hypothesis comes from a recent study of the effect of PDE3A ablation on oocyte maturation. 15 Consistent with the CREM-null phenotype, female PDE3A À/À mice are completely sterile due to arrested oocyte development in the germinal vesicle stage. 15 In conclusion, PDE11 is located in the testis and spermatozoa and appears to be involved in the regulation of sperm physiology. These data support a role for PDE11 in the regulation of sperm activation, and perhaps development, via regulation of cAMP in the testis and spermatozoa, and are consistent with the pivotal role played by cAMP in sperm function/physiology. Specifically, PDE11 maintains sperm in an uncapacitated state prior to ejaculation and regulates forward movement following ejaculation. These data indicate that agents that inhibit PDE11 have the potential to disrupt regulation of spermatozoa cAMP, and as a result may have detrimental effects on sperm physiology and lead to reduced fertilization ability. Further investigations are needed to clarify the role of PDE11 in sperm function and fertilization. Figure 4 Schematic representation of the putative role of PDE11 in sperm capacitance. Activating ligand odorants, such as bourgeonal, lilial and floralozone, activate the human testicular olfactory receptor, hOR17-4, increase neuronal and endothelial nitric oxide (NO) release, and stimulate cAMP synthesis by mAC and sAC. cAMP increases Ca 2 þ entry via CatSper, a spermspecific cAMP-activated Ca 2 þ channel, and protein phosphorylation via protein kinase A (PKA). Intracellular Ca 2 þ and protein phosphorylation lead to membrane depolarization, resulting in activation of capacitance and the acrosome reaction. PDE11 regulates intracellular cAMP and maintains pre-ejaculated sperm in a decapacitated state for proper fertilization potential.
